Cascade Investment Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-58
Closed -$11.5K 164
2023
Q1
$11.5K Buy
+58
New +$11.9K 0.01% 210
2022
Q3
Sell
-58
Closed -$11.7K 163
2022
Q2
$11.7K Hold
58
0.01% 215
2022
Q1
$13.2K Hold
58
0.01% 234
2021
Q4
$15.7K Hold
58
0.01% 224
2021
Q3
$14.1K Hold
58
0.01% 220
2021
Q2
$13.8K Hold
58
0.01% 221
2021
Q1
$12.8K Hold
58
0.01% 223
2020
Q4
$10.2K Hold
58
0.01% 232
2020
Q3
$9.41K Hold
58
0.01% 224
2020
Q2
$8.3K Hold
58
0.01% 223
2020
Q1
$6.32K Hold
58
0.01% 225
2019
Q4
$8.46K Hold
58
0.01% 233
2019
Q3
$8.4K Hold
58
0.01% 234
2019
Q2
$8.64K Hold
58
0.01% 221
2019
Q1
$7.65K Hold
58
0.01% 211
2018
Q4
$6.32K Buy
+58
New +$7.77K 0.01% 211

Other funds holding LH

Cascade Investment Advisors's LH Position: Q2 2023 in Review

Cascade Investment Advisors sold out of Labcorp (LH) in Q2 2023, closing a stake of 58 shares — an estimated $11.5K sold.

Cascade Investment Advisors first reported a position in LH in Q4 2018 and held it in 16 quarters. The position peaked at $15.7K in Q4 2021. 932 funds tracked by Wall St. Rank hold LH as of Q2 2023.

  • Cascade Investment Advisors reported no remaining Labcorp position as of Q2 2023 after selling out during the quarter.
  • Cascade Investment Advisors sold 58 Labcorp shares in Q2 2023, an estimated $11.5K.
  • Cascade Investment Advisors first reported a position in Labcorp in Q4 2018 and held it in 16 quarters.
  • Cascade Investment Advisors's Labcorp position peaked at $15.7K in Q4 2021.
  • 932 funds tracked by Wall St. Rank held Labcorp as of Q2 2023.

Based on Cascade Investment Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.